openPR Logo
Press release

Global Joint Reconstruction Devices Market was valued at USD 20.64 million in 2021

07-21-2022 08:11 AM CET | Health & Medicine

Press release from: DelveInsight Business Research

Joint Reconstruction Devices Market

Joint Reconstruction Devices Market

Global Joint Reconstruction Devices Market was valued at USD 20.64 million in 2021, growing at a CAGR of 6.01% during the forecast period from 2022 to 2027, in order to reach USD 29.10 million by 2027. The Joint Reconstruction Devices market is expected to witness growth due to a rise in the prevalence of joint-related diseases such as arthritis, bone degenerative diseases, osteoporosis, gout, and injuries, growing technological advancements in product development, increasing awareness for minimally invasive procedures, and surge in the geriatric population.

Joint Reconstruction Devices: An Overview

Joint Reconstruction Devices are medical devices that are used to rebuild a joint's architecture to recover its functions. Joint reconstructive surgery, a minimally invasive procedure offers relief to individuals suffering from joint disorders and fractures. Total hip replacement, total knee replacement, and anterior cruciate ligament are some of the joint reconstruction methods. Joint reconstruction involves a wide range of treatments including pain management, surgery, and physiotherapy.

Download a sample copy of the report- https://www.delveinsight.com/sample-request/joint-reconstruction-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Recent Developmental Activities in the Joint Reconstruction Devices Market:

• In August 2021, the US FDA approved the Persona IQ and awarded a de novo classification grant and authorization to Zimmer Biomet and Canary Medical to market the tibial extension for Persona IQ for total knee replacement surgery.
• In March 2021, Premia Spine received FDA breakthrough device designation for TOPS™ Spinal Arthroplasty System.

Key Takeaways from the Joint Reconstruction Devices Market Report Study

• Market size analysis for current Joint Reconstruction Devices market size (2021), and market forecast for 5 years (2022-2027)
• The effect of the COVID-19 pandemic on this Joint Reconstruction Devices market is significant. To capture and analyze suitable indicators, our experts are closely watching the Joint Reconstruction Devices market.
• Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
• Key companies dominating the Global Joint Reconstruction Devices Market.
• Various opportunities are available for the other competitor in the Joint Reconstruction Devices Market space.
• What are the top-performing segments in 2021? How these segments will perform in 2027.
• Which are the top-performing regions and countries in the current market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Joint Reconstruction Devices market growth in the coming future?

COVID19 Impact on Joint Reconstruction Devices Market

The outbreak of the COVID-19 pandemic had a profound impact across the globe. The pandemic led to the cancellation of outpatient visits and the suspension of non-emergency hospitals and procedures. This resulted in the reduced number of routine clinical examinations of the orthopedical visits and related procedures. Thus, the number of patients waiting to get Joint Reconstruction procedures done through surgery increased over time. Therefore, the demand for Joint Reconstruction Devices has decreased for the short period of time. However, certain factors like infections caused around the prosthesis, blood clotting, and malfunctioning of the prosthesis may restrict the growth of the Global Joint Reconstruction Devices Market.

Do you know about the Joint Reconstruction Devices Market Share? Visit here- https://www.delveinsight.com/report-store/joint-reconstruction-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Joint Reconstruction Devices Market Dynamics
Joint Reconstruction Devices Market has significantly increased owing to a rise in the prevalence of joint-related disorders such as arthritis, bone degenerative diseases, osteoporosis, gout, and injuries. Different types of arthritis require the use of Joint Reconstruction Devices, as per CDC 2020, more than 32.5 million US adults have osteoarthritis. Moreover, 62% of people with osteoarthritis are women in the US, as per Osteoarthritis Action Alliance, 2021

Joint Reconstruction Devices Market
Additionally, the Joint Reconstruction Devices Market is witnessing a significant growth in product demand owing to the increasing geriatric population base across the globe. According to the data provided by the World Health Organization, in 2020, about one billion people across the world were over the age of 60. The source further stated that by 2050, the elderly population in the 60 and above age group is expected to double in number representing about 2.1 billion people, and people in the age group of 80 and above are estimated to triple between 2020 and 2050 reach 426 million.
Moreover, as per the CDC 2021, arthritis prevalence increases with age. Thus, the rising elderly population is expected to lead to the rise in the arthritis patient population across the world, which in turn would lead to an increase in demand for Joint Reconstruction Devices during the forecast period, which will drive the Joint Reconstruction Devices market growth around the globe.

Joint Reconstruction Devices Market Segment Analysis
• Joint Reconstruction Devices Market by Joint Type (Knee Reconstruction, Hip Reconstruction, Shoulder Reconstruction Others),
• Joint Reconstruction Devices by Technique (Joint Replacement, Arthroplasty, Osteotomy, Resurfacing Surgery, Others),
• Joint Reconstruction Devices by End-user (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers (ASC), Others), and
• Joint Reconstruction Devices by Geography (North America, Europe, Asia-Pacific, and Rest of the World).

Global Joint Reconstruction Devices Market is expected to dominate the North America

North America is expected to dominate the overall Joint Reconstruction Devices market during the forecast period. This domination is due to the rising prevalence of joint-related diseases such as arthritis, bone degenerative diseases, osteoporosis, gout, and injuries. As per the Centers for Disease Control and Prevention 2021, about 1 in 4 US adults (23.7%) or about 58.5 million people have doctor-diagnosed arthritis in the United States. Additionally, by the year 2040, an estimated 78.4 million adults aged 18 years and older (25.9% of the projected total adult population) will have doctor-diagnosed arthritis in the US.

Joint Reconstruction Devices Market Companies

Some of the key market players operating in the Global Joint Reconstruction Devices Market include Medtronic PLC, Zimmer Biomet, Stryker, NuVasive®, Inc., Smith & Nephew PLC, CONMED Corporation, DJO, LLC (Colfax Corporation), MicroPort Scientific Corporation, Globus Medical, Arthrex, Inc., Corin Group, Integra LifeSciences, Johnson & Johnson, OMNIlife science™, Inc., Exactech, Inc., B. Braun Melsungen AG, Medacta International, among others.

Request a sample copy of the market- https://www.delveinsight.com/sample-request/joint-reconstruction-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Content
1. Joint Reconstruction Devices Market Report Introduction
2. Joint Reconstruction Devices Market Executive summary
3. Regulatory and Patent Analysis
4. Joint Reconstruction Devices Market Key factors analysis
5. Joint Reconstruction Devices Porter's Five Forces Analysis
6. COVID-19 Impact Analysis on Joint Reconstruction Devices Market
7. Joint Reconstruction Devices Market layout
8. Joint Reconstruction Devices Global Company Share Analysis - Key 3-5 Companies
9. Joint Reconstruction Devices Company and Product Profiles
10. KOL Views
11. Project Approach
12. About DelveInsight
13. Disclaimer & Contact Us

For any query or doubt, visit here- https://www.delveinsight.com/report-store/joint-reconstruction-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Contact Us
Yash
info@delveinsight.com

About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Joint Reconstruction Devices Market was valued at USD 20.64 million in 2021 here

News-ID: 2686370 • Views:

More Releases from DelveInsight Business Research

Global Uterine Fibroids Treatment Devices Market is projected by DelveInsight to grow at a CAGR of 8.57% by 2032, states DelveInsight
Global Uterine Fibroids Treatment Devices Market is projected by DelveInsight to …
DelveInsight's latest publication, "Uterine Fibroids Treatment Devices Market Insights, Competitive Landscape and Market Forecast-2032," offers a comprehensive evaluation of the current market status, future opportunities, upcoming technological advancements, key challenges, and major growth determinants. The report also highlights breakthrough products under development and profiles the prominent companies actively shaping the Uterine Fibroids Treatment Devices industry. According to DelveInsight's analysis, the growing prevalence of uterine fibroids particularly among women of reproductive age
Global AI in Remote Patient Monitoring Market Forecasted to Grow at 27.13% CAGR Through 2032, Reports DelveInsight
Global AI in Remote Patient Monitoring Market Forecasted to Grow at 27.13% CAGR …
According to DelveInsight's analysis, North America is expected to dominate the Artificial Intelligence (AI) in Remote Patient Monitoring market from 2025 through 2032. This strong regional performance is attributed to the growing burden of chronic illnesses including cancer well-established healthcare infrastructure, rapid adoption of digital health technologies, and supportive government policies. Additionally, increased investment in digital health and the widespread use of wearables and connected medical devices are significantly accelerating
DelveInsight Strengthens Pharma Decision-Making with Advanced Competitive Intelligence News Monitoring Solutions
DelveInsight Strengthens Pharma Decision-Making with Advanced Competitive Intell …
As the pharmaceutical industry accelerates toward rapid innovation and heightened competition, access to timely, actionable intelligence has become indispensable. DelveInsight, a premier life sciences market research and consulting organization, has launched an enhanced Competitive Intelligence (CI) News Monitoring service designed to equip pharmaceutical companies with real-time insights into clinical, regulatory, and commercial developments. This solution is reshaping how organizations interpret market shifts and make evidence-based strategic decisions. Stay Ahead of the
DelveInsight Releases In-Depth Market & Competitive Intelligence Report on the Global Cell Imaging Technology Landscape to Guide Strategic Commercial Decisions
DelveInsight Releases In-Depth Market & Competitive Intelligence Report on the G …
DelveInsight, a prominent provider of life sciences market research and strategic consulting, has announced the publication of its latest analytical report, "Market & Competitive Assessment: Mapping Commercial Success in the Cell Imaging Technology Domain." This comprehensive study delivers a rigorous, data-driven evaluation of the worldwide market for cell imaging and analysis systems, with a dedicated focus on software-enabled platforms such as High-Content Screening (HCS) instruments, flow cytometers, and cell analyzers.

All 5 Releases


More Releases for Joint

"Joint Genesis Launches Revolutionary Natural Supplement for Joint Pain Relief & …
Joint Genesis has officially launched its breakthrough natural supplement designed to provide effective joint pain relief, improve mobility, and support long-term joint regeneration. This scientifically inspired formula combines powerful natural ingredients to help adults maintain an active lifestyle, reduce stiffness, and support overall joint health. Joint GenesisTM is ideal for anyone looking for a safe, natural alternative to traditional painkillers. Customers can purchase the supplement online at https://us-jointgenesisis.com and experience
Arthro MD+ Joint Support - Enhance Mobility And Joint Stability!
As we age or engage in physically demanding activities, our joints often take the brunt of the damage. Stiffness, pain, and reduced flexibility can limit mobility and affect our quality of life. This is where Arthro MD+ Joint Support comes into play. In this comprehensive guide, we will explore everything you need to know about this joint supplement, from its benefits to how it works, customer reviews, and more. By
Pharma Flex RX Joint Support™ Healthy Joint Mobility Flexibility!
Are you tired of living with joint pain, inflammation, and arthritis? Pharma Flex RX Joint Support is here to help. This is made to ease your joint pain and support your health. It uses natural ingredients that work together to fix the real causes of your joint pain. This means you can move freely and enjoy your life again. ● Product Name - Pharma Flex RX Joint Support ● Results - In
BioDynamix Joint Genesis - Time To Say Bye To Joint Pain (Joint Genesis Reviews)
What is BioDynamix Joint Genesis? BioDynamix Joint Genesis is a doctor-formulated supplement designed to treat joint pain and discomfort. The formula rejuvenates and restores your joints, offering a pain-free life. BioDynamix Joint Genesis ensures you enjoy flexibility, movement, and independence for a long time. It soothes all kinds of joint inflammation and combats stiffness. The formula works by addressing the underlying cause of joint issues. BioDynamix Joint Genesis works for adults between ages
Revolutionizing Sacroiliac Joint Treatment: Minimally Invasive Sacroiliac Joint …
Minimally Invasive Sacroiliac Joint Fusion (MIS-SIJ Fusion) is a surgical procedure for treating sacroiliac joint disorders, where the sacroiliac joint is stabilized through minimally invasive techniques. MIS sacroiliac joint fusion is a less invasive alternative to traditional open sacroiliac joint fusion and is gaining popularity among patients and healthcare providers. The MIS sacroiliac joint fusion market is expected to grow significantly in the coming years, driven by the increasing demand
Flexotone Joint Pain Relief Reviews: Get Relief from Joint Pain & Arthritis
Joint pain & inflammation has come to be an instead usual problem among older consumers, as well as they are frequently entrusted to identify exactly how to deal with these problems with a topical cream or resting. Nevertheless, the makers behind Flexotone think that the reason behind this concern has every little thing to do with something that takes place within the joints. This trouble triggers unbelievable pain; however Big